EyeBio vs PulseSight Therapeutics
EyeBio
Developing a new generation of therapies to protect, restore, and improve vision
109 employees · est. 2021 · London, United Kingdom
EyeBio is the larger of the two.
Side-by-Side Comparison
| Metric | EyeBio | PulseSight Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2021 | Not tracked yet |
| Headquarters | ||
| Headquarters | London, United Kingdom | Paris, France |
| Employees | ||
| Employees | 109 larger | 9 |
| Industry | ||
| Industry | Biotechnology | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Acquired | Seed |
| Total Funding | ||
| Total Funding | $3.13B | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 4 | 1 |
| Services | ||
| Services | Research and Development, Therapeutic Modalities, Clinical Trials, Patient Support Programs, Business Development and Licensing, Philanthropy and Medical Outreach | Development of non-viral vectorized therapies for ophthalmic applications, focusing on treatments for retinal diseases such as age-related macular degeneration (AMD) |
| Target Customers | ||
| Target Customers | Patients with Retinal Diseases, Healthcare Professionals, Research Scientists, Pharmaceutical Distributors, Investors, Healthcare Institutions | Patients with retinal diseases, healthcare professionals, ophthalmologists, biotech and pharmaceutical companies, investors |
| Taxonomy | ||
| Taxonomy | OphthalmologyBiopharmaceuticalsVision TherapyEye DiseasesAge-related Macular DegenerationAnti-vascular Endothelial Growth Factor +8 | OphthalmologyDrug DevelopmentGene TherapyEye DiseasesNon-viral Gene TherapyMinimally-invasive Delivery +5 |
| Website | ||
| Website | eyebiotech.com | pulsesighttherapeutics.com |
About EyeBio
EyeBio, founded in 2021, is an innovative biotechnology company based in the United Kingdom, specializing in ophthalmology. The company's driving mission, encapsulated in its slogan—"Developing a new generation of therapies to protect, restore, and improve vision"—focuses on addressing the unmet nee...
About PulseSight Therapeutics
PulseSight Therapeutics is a biotechnology startup based in France that specializes in ophthalmology drug development. The company is focused on creating non-viral gene therapies and minimally-invasive delivery technology to address major eye diseases. Their ultimate goal is to provide life-changing...
Also comparing in this category
Comparing more than these two?
Get EyeBio, PulseSight Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does EyeBio compare?
A PDF of EyeBio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare EyeBio with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at EyeBio on 28 Jan 2026, and PulseSight Therapeutics on 7 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
